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Background: Antimicrobial prophylaxis is crucial for neurosurgical procedures, even though they are clean 
procedures. Observational studies have shown the effectiveness of different antibiotics in preventing neurosurgical 
site infections, but there remains paucity of systematic reviews and meta-analyses which have assessed their 
effectiveness in East Africa.  
Objectives: To generate and appraise the quality of evidence that would inform antimicrobial prophylaxis in 
neurosurgery.  
Methodology: A systematic review and meta-analysis was conducted between October 2014 and December 2015. 
Studies that involved the administration of systemic antibiotics for prophylaxis, use of antibiotic impregnated shunt 
catheters among adult patients aged over 18 years were included and subjected to abstract, title and full text 
screening. A meta-analysis was carried out using RevMan (Review Manager) version 5 software. The quality of 
evidence was evaluated using the GRADE system.  
Results: One systematic review of randomized controlled trials (n=17) and 11 randomised controlled trials were 
included in the study. From the first meta-analysis, use of systemic antibiotics demonstrated an overall protective 
effect of 52% from development of surgical site infections [OR 0.48 (95% CI 0.30, 0.79)]. In the second meta-analysis, 
the use of antibiotic impregnated shunt catheters was associated with a higher risk of mortality compared to use of 
the standard shunt [(OR 1.47(95% CI 0.82, 2.62)]. Following evaluation of quality of evidence, in the antibiotics versus 
placebo arm, the quality of evidence was moderate, while that for antimicrobial impregnated shunts was very low.  
Conclusion: Antimicrobial prophylaxis using systemic antibiotics or antimicrobial impregnated shunts is effective in 
preventing neurosurgical site infections. Antimicrobial impregnated shunts are too expensive for our study 
population.  
Key words: systematic review, meta-analysis, antimicrobial prophylaxis 
Received: August, 2016  
Published: February, 2017 
 
1. Introduction 
Surgical site infections are infections that occur after 
surgical procedures at and around the incision site or at 
distant sites. Neurosurgical procedures involve the 
surgical management of conditions that affect the brain, 
spinal cord, peripheral nerves and their surrounding 
tissues as well as vascular conditions of the head and 
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neck (Chiang et al, 2014). They have a low rate of 
surgical site infections because they are not associated 
with entry into potentially contaminated fields like 
gastrointestinal and genitourinary tracts.  However, 
when infections occur, they lead to high morbidity and 
mortality (Walcott et al, 2012).  
Antimicrobial prophylaxis, in which antibiotics are 
given during the peri-operative period to prevent these 
infections, has been shown to reduce their incidence 
(Chiang et al, 2014). Systemic antimicrobial 
prophylaxis, in which antibiotics are given 
intravenously, intramuscularly or orally has commonly 
been used. In the early 2000s, antimicrobial 
impregnated shunts and catheters (AICs) were 
introduced and are commonly used, particularly in 
developed countries. They include ventriculo-peritoneal 
shunts and ventriculo-atrial shunts, which are used to 
drain excess cerebrospinal fluid in patients with 
hydrocephalous, from the ventricles of the brain to 
other parts of the body like the peritoneum or atrium 
for excretion. When impregnated with antibiotics, they 
have been shown to reduce the incidence of 
neurosurgical site infections (Ratilal, 2008).  
Many studies have explored the use of systemic 
antibiotics and antimicrobial impregnated shunts and 
catheters (AICs)  for prophylaxis in neurosurgery, and 
demonstrated differences in effectiveness, with some in 
favour of AICs and others reporting no difference in 
effectiveness (Ratilal, 2008). There is a paucity of 
randomised controlled trials and systematic reviews on 
this from developing countries. The main objective of 
this systematic review was to generate and appraise the 
quality of evidence that would inform antimicrobial 
prophylaxis in neurosurgery at Kenyatta National 
Hospital and other hospitals performing neurosurgery 
in low income countries. 
2. Materials and Methods 
2.1 Selection of Studies, PICO and Search Strategy  
 A systematic review and meta-analysis was conducted 
between October 2014 and December 2015. The 
research question, which incorporates the Population, 
Intervention, Comparison and Outcome (PICO) aspects 
was formulated. The population (P) of interest was 
“adult neurosurgical patients”, while the intervention 
(I) was antimicrobial prophylaxis. The comparator 
/control (C) was “no antimicrobial prophylaxis or 
placebo” while the outcomes of interest (O) were all-
cause mortality, development of neurosurgical site and 
non-surgical site infections, shunt revision and adverse 
effects of antibiotics. Antimicrobial prophylaxis was 
defined as the use of systemic antibiotics or antibiotic 
impregnated shunt catheters for the prevention of 
neurosurgical site infections.  The search was done 
between October 2014 and December 2014.  
All-cause mortality was defined as death from any cause 
during the course of treatment. Surgical site infections 
were defined as infections occurring at and around the 
surgical site according to the CDC classification 
(Mangram et al, 1999). Non-surgical site infections were 
defined as any other infections at distant sites, not 
directly related to the surgery. Shunt revision was 
defined as the removal or replacement of a shunt 
through a subsequent surgical procedure, due to 
development of surgical site infection (Zabramski, 
2003).   Adverse effects of antibiotics were defined as 
any untoward effects on the patient arising from use of 
antimicrobials (Goodman and Gillman, 2016).  
The PICO question formulated was “For adult 
neurosurgical patients, does antimicrobial 
prophylaxis compared to no antimicrobial 
prophylaxis, reduce the risk of development of 
surgical site infections?” 
The following search strategy was formulated using 
Medical Subject Headings (MeSH) terms and was then 
entered into the search databases. “(Effectiveness OR 
Efficacy) AND (antibiotics OR antimicrobials OR 
antiinfectives) AND (Prophylaxis OR Prevention) 
AND (infection control) AND (neurosurgical OR 
neurosurgery OR neurosurgical site infections)”. 
2.2 Inclusion and Exclusion Criteria for the Studies  
We sought to include systematic reviews and 
randomised controlled trials which addressed the 
population, interventions, comparators and outcomes of 
interest. Specifically, we sought to include studies that 
evaluated our patient population of interest (patients 
over 18 years old, undergoing neurosurgical 
procedures, including spinal instrumentation surgery), 
interventions of interest (administration of systemic 
antibiotics for antimicrobial prophylaxis versus no 
antibiotics or placebo, or the use of antibiotic 
impregnated shunts, catheters and drains versus 
standard shunts), and our outcomes of interest (all-
cause mortality, development of surgical site and non-
surgical site infections as well as adverse effects of 
antibiotics). Studies that involved paediatric patients, 
those that compared two different antibiotics and 
studies involving local irrigation of wounds using 
antiseptics were excluded. Studies which were not in 
English and could not be translated were also excluded 
from the review. We also excluded studies that were not 
either systematic reviews or randomised controlled 
trials. No restrictions on publication date were set.  
2.3 The Search 
Two investigators carried out the search and study 
selection independently and sorted the differences by 
discussion and consensus building. Separate searches 
were done for systematic reviews and for randomized 
controlled trials (RCTs). For the Systematic Reviews, the 
search strategy was entered into MEDLINE and the 
Cochrane Database of Systematic Reviews (CDSR). The 
search was filtered as “Reviews”. This yielded 16 
systematic reviews. The same was repeated for the 
randomised controlled trials, with the search being 
filtered for “randomised controlled trials” into the 
MEDLINE database and the Cochrane Central Register 
for Controlled Trials (CENTRAL). This yielded 31 
results.  
2.4 Screening, Full Text Analysis and Data 
Abstraction 
Title and abstract screening and full text analysis was 
done to select the eligible studies as illustrated in 
Figure 1. 
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Figure 1: PRISMA Flow Diagram for the Included Studies 
2.5 Evaluation of the Quality of Evidence  
Two meta-analyses were performed, based on the 
interventions. The first intervention considered was 
antibiotics versus placebo; the second intervention 
focused on antibiotic impregnated shunt catheters 
versus standard shunts.  
The quality of evidence was evaluated using GRADE. 
3. Results 
META-ANALYSIS 1: Antibiotics versus Placebo/ No 
Antibiotics  
Development of Surgical Site Infections 
From this meta-analysis, use of systemic antibiotics 
demonstrated an overall protective effect of 52% from 
development of surgical site infections [OR 0.48 (95% 
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CI 0.30, 0.79)]. 48 out of 100 patients are more likely to 
develop surgical site infections if they are not on 
antimicrobial prophylaxis. In six studies, use of 
antimicrobial prophylaxis demonstrated a protective 
effect (Blomstedt 1985, n=174; Bullock 1988, n=417; 
Djindjian 1990, n=356; Petignat 2008, n=1,237; Young 
1987, n=846;  and Zentner 1995, n=129). There was low 
observed heterogeneity across the studies as the I2 
statistic was 19%. Generally, an I2 statistic of above 
40% indicates significant heterogeneity across studies 
(Schunemann et al, 2013) (Figure 2).   
Non-Surgical Site Infections (NSSIs) 
Two studies, (Djindjian 1990 and Petignat 2008), which 
used systemic antibiotics versus no antibiotics, 
evaluated patients for development of non-surgical site 
infections. A total of 784 patients were on antibiotics 
while 809 patients were on no antibiotic or placebo. The 
average effect size of the studies for this outcome was 
about 1 [OR 1.04 (95% CI 0.60, 1.82)].  However, there’s 
a slight leaning of the studies towards placebo, or no 
antibiotics, but this is not significant. Overall, there was 
no difference in development of NSSIs between patients 
who were on antibiotics or those who were on placebo. 
This means that development of non-surgical site 
infections is not prevented by antimicrobial 
prophylaxis. The I2 statistic is zero, which suggests no 
heterogeneity between the effect sizes of the two 
studies (Figure 3). 
There were no events reported for the following 
outcomes: all-cause mortality, Shunt Revision and 
adverse effects of antibiotics.  
Grading of Evidence for Systemic Antibiotics versus 
No Antibiotics/Placebo 
GRADE Pro GDT version 2015 software was used to 
evaluate the quality of evidence. The 8 RCTs were 
assessed for study design, risk of bias, inconsistency, 
indirectness and imprecision. The outcome measures 
were rated as critical or important depending on the 
impact to patients. Overall, the evidence for 
antimicrobial prophylaxis was of moderate quality 
(Table 1).  
 
 
Figure 2: Forest Plot for Surgical Site Infections 
 
 
 
Figure 3: Forest Plot for Non-Surgical Site Infections 
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Table 1: GRADE Summary of Findings for Antimicrobial Prophylaxis versus Placebo 
Antimicrobial prophylaxis compared to placebo or no antimicrobial prophylaxis for prevention of neurosurgical site 
infections 
Patient or population adult neurosurgical patients  
Setting low and middle income countries  
Intervention antimicrobial prophylaxis  
Comparison placebo or no antimicrobial prophylaxis  
Outcomes Anticipated absolute effects* (95% CI)  Relative 
effect 
(95% CI)  
№ of 
participants  
(studies)  
Quality of the evidence 
(GRADE)  
Importance 
Risk with placebo or no 
antimicrobial 
prophylaxis 
Risk with 
antimicrobial 
prophylaxis  
Development of surgical site infections 
(SSIs) 
assessed with wound infection, positive 
cultures, CDC classification, Malis Criteria, 
fever, leukocytosis, clinical signs 
follow up range 1 weeks to 1 years  
Study population  OR 
0.48 
(0.30 to 
0.79)  
2260 
(8 RCTs)  
⨁⨁⨁◯ 
MODERATE 1 
CRITICAL 
 
51 per 1000  
25 per 1000 
(16 to 41)  
Development of non-surgical site infections 
(NSSIs) 
assessed with pneumonia, UTIs 
follow up range 1 weeks to 6 months  
Study population  OR 
1.04 
(0.60 to 
1.82)  
1593 
(2 RCTs)  
⨁⨁⨁◯ 
MODERATE 1 
CRITICAL 
32 per 1000  
33 per 1000 
(20 to 57)  
Development of adverse effects of 
antibiotics (A/Es) 
assessed with Clinical signs 
follow up mean 6 months  
Study population  not 
estimable  
1366 
(2 RCTs)  
⨁⨁⨁◯ 
MODERATE 1 
IMPORTANT 
0 per 1000  
0 per 1000 
(0 to 0)  
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and 
its 95% CI).  
 
CI Confidence interval; RR Risk ratio; OR Odds ratio;  
GRADE Working Group grades of evidence 
High quality We are very confident that the true effect lies close to that of the estimate of the effect 
Moderate quality We are moderately confident in the effect estimate The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is 
substantially different 
Low quality Our confidence in the effect estimate is limited The true effect may be substantially different from the estimate of the effect 
Very low quality We have very little confidence in the effect estimate The true effect is likely to be substantially different from the estimate of effect  
1. unclear allocation concealment, random sequence allocation, blinding, incomplete outcome data, selective reporting for all studies 
 
Development of Surgical Site Infections  
A total of 2,260 patients were included in all the 8 
studies evaluated this outcome. Patients who were on 
antimicrobial prophylaxis were less likely to develop 
surgical site infections compared to those who were on 
placebo or no antibiotic. 28 out of 1117 patients on 
antimicrobial prophylaxis developed infection while 58 
out of 1143 of those without prophylaxis developed 
infection [OR 0.48 (95% CI 0.30. 0.79)]. The overall 
quality of evidence for this critical outcome was 
moderate.  
Risk of Bias  
There was a high risk of bias in the included studies as 
illustrated in Figure 4. 
Indirectness  
There was no indirectness with regard to population. 
All the studies that were included had patients with 
characteristics that match our patient population. It 
should however be noted that most of the studies were 
carried out in high income countries. Race and ethnicity 
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could influence the pharmacokinetic, pharmacodynamic 
profiles and effectiveness of the antibiotics.  
Adult patients undergoing neurosurgical procedures 
were given antibiotics for prophylaxis systemically. The 
antibiotics administered are available in our settings. 
Indirectness due to intervention does not therefore 
arise. The criteria used to evaluate this outcome 
measure in the systematic review are similar to the 
methods used in evaluating such outcomes in our study 
setting. 
Imprecision  
We applied the optimal information size (OIS) rule 
(Schunemann et al; 2013) to test for imprecision across 
this outcome and it was not noted. Additionally, the 
confidence interval for the estimate of effect is narrow 
and does not include 1. The events on the control arm 
are twice as many as the events in the treatment arm.  
Inconsistency  
Using the eye ball test, the confidence intervals were 
found to be overlapping. The Chi squared test yielded a 
p value of 0.28, which is greater than 0.05, which 
implies low heterogeneity across studies. The I2 statistic 
was 19%, (<40%), which implies homogeneity across 
included studies (Schunemann et al; 2013).  
Publication Bias  
A comprehensive search was carried out in the accessed 
databases for these studies to minimise publication 
bias. The studies obtained were too few to generate a 
funnel plot, so publication bias could not be detected.  
Development of Non-Surgical Site Infections 
Two trials, (Djindjian 1990; and Petignat et al, 2008) 
considered this as a secondary outcome. Non- surgical 
site infections were defined as a diagnosis of 
pneumonia, urinary tract infections and sepsis.  A meta- 
analysis gave the estimate of effect for this outcome as 
shown in Figure 3. The five GRADE criteria were used 
to evaluate the quality of evidence for this outcome.  
Risk of Bias 
The risk of bias for these two studies is summarized in 
Figure 5. 
 
 
Figure 4: Risk of Bias Summary Review Authors' Judgments about Each Risk of Bias Item for Each Included Study. 
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Figure 5: Risk of Bias Summary Review: Authors' Judgments about Each Risk of Bias Item for Each Included Study. 
 
Indirectness 
There was no significant indirectness with regard to 
population, interventions, their applicability and 
outcome measures to warrant downgrading the 
evidence for this outcome to moderate quality.  
Inconsistency 
The eyeball test shows overlapping confidence 
intervals. The p value from the Chi square test is 0.91, 
while the I2 statistic for all studies form the meta-
analysis was 0% less than 40%, which showed minimal 
heterogeneity as shown in Figure 3. There was 
therefore no inconsistency.  
Imprecision  
There was a wide confidence interval which included 1. 
The total number of events in the included studies was 
few. On applying the OIS rule, imprecision was detected.  
Publication bias  
This could not be detected because the studies 
generated from a comprehensive search were too few 
to generate a funnel plot. 
Development of Adverse Effects of Antibiotics 
From the meta-analysis, there were no events reported, 
although 2 studies (Petignat et al; 2008 and Zentner, 
1995) assessed the outcome. The estimate of effect for 
this outcome could therefore not be obtained. High risk 
of bias warranted the downgrading of the quality of 
evidence to moderate. Since there were no events and 
confidence intervals, it was not possible to assess 
imprecision. Inconsistency of results was not detected, 
neither was publication bias.  
 
META-ANALYSIS 2 Antimicrobial Impregnated 
Shunt Catheters versus Standard Shunts 
In a second meta- analysis, the use of antibiotic 
impregnated shunt catheters (AICs) versus use of 
standard shunts was evaluated. Two studies (Govender 
2003 and Zabramski 2003), were included in the meta-
analysis and evaluated two outcomes: all -cause 
mortality and surgical site infections (Figure 6). 
The use of antibiotic impregnated shunt catheters was 
associated with a higher risk of mortality compared to 
the use of the standard shunt [(OR 1.47(95% CI 0.82, 
2.62)]. This is corroborated in the individual studies; 
Govender 2003 [(OR 2.11 (95% CI 0.48, 9.31)], where 
patients with AICs were twice as likely to die compared 
to those with standard shunts and Zabramski 2003 [(OR 
1.38 (95% CI 0.74, 2.58)], where patients with AICs 
were 1.4 times more likely to die than those with 
standard shunts.  
Risk of Bias  
Govender 2003 and Zabramski 2003 had a high risk of 
bias as illustrated in Figure 7. This warranted 
downgrading of the evidence to moderate quality.  
Indirectness  
There was indirectness with respect to intervention. 
Antimicrobial impregnated shunts are not commonly 
used in our setting because they are too expensive. One 
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AIC costs approximately Ksh. 40,000 (US Dollars 400), 
which is beyond the reach of the patients who are 
treated at Kenyatta National Hospital. This warranted 
the downgrading the level of evidence from moderate to 
low quality.  
Inconsistency  
The eyeball test on the forest plot revealed overlapping 
confidence intervals. The p value from the Chi square 
test was 0.39, and the I2 statistic was zero, hence no 
inconsistency for this outcome.  
Imprecision  
There was Imprecision because the included studies did 
not comply with the OIS rule.  There were also wide 
confidence intervals. This led to the downgrading of 
evidence from low quality to very low quality evidence.  
 
 
 
Figure 6: All-cause Mortality 
 
 
 
Figure 7: Risk of Bias for All-cause Mortality 
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Figure 8: Surgical Site Infections 
 
 
 
Figure 9: Risk of bias 
 
Publication bias  
The studies obtained were too few to generate funnel 
plots, so we were not able to detect publication bias. 
Figure 8 presents the results of the meta-analysis. 
The use of AICs has a strong protective effect against 
development of surgical site infections [OR 0.22 (95% 
CI 0.08, 0.59)]. The protective effect of AIC is about five 
times greater than that of standard shunts.  
Risk of bias, Inconsistency, Imprecision and 
Publication bias    
Govender 2003 and Zabramski 2003 were associated 
with a high risk of bias as shown in Figure 9.  
Inconsistency, Imprecision and publication bias were 
similar to the outcome on development of surgical site 
infections. 
Shunt Revision 
One study, Govender 2003 evaluated this outcome. 
Patients were less likely to undergo shunt revision with 
AICs, compared to standard shunts [(OR 0.66 (95% CI 
0.26, 1.67)].  
There was a high risk of bias in this study. Therefore, 
the quality of evidence was downgraded from high to 
moderate quality. Since it was a single study, 
inconsistency could not be determined for this outcome. 
Imprecision was noted because of the wide confidence 
intervals and few events. This warranted downgrading 
of the level of evidence from moderate to low. There 
was indirectness with respect to intervention. 
Antimicrobial impregnated shunts are not commonly 
used in our setting because they are too expensive as 
described earlier. Outcomes 3 and 5 (development of 
non-surgical site infections and adverse effects of 
antibiotics) were not evaluated. 
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Overall Quality of Evidence for AICS versus Standard 
Shunts  
GRADE Pro GDT Software version 2015 was used to 
evaluate the quality of evidence for this intervention. 
The quality of evidence supporting the use of AICs in 
our setting was very low, due to serious indirectness, 
risk of bias and imprecision for all the critical outcomes, 
as presented in Table 2. 
 
Table 2: Quality of Evidence for AICs versus Standard Shunts 
Antimicrobial impregnated shunts compared to standard shunts for prevention of neurosurgical site infections 
Patient or population adult neurosurgical patients  
Setting low and middle income countries  
Intervention antimicrobial impregnated shunts  
Comparison standard shunts  
Outcomes Anticipated absolute effects* (95% CI)  Relative 
effect 
(95% CI)  
№ of 
partiipants  
(studies)  
Quality of the evidence 
(GRADE)  
Comments 
Rsk with 
standard 
shunts 
Risk with 
antimicrobial 
impregnated shunts 
Development of surgical site infections (SSIs) 
assessed with wound infection, positive cultures, CDC 
classification, Malis Criteria, fever, leukocytosis,shunt 
infection clinical signs 
follow up range 1 weeks to 20 months  
Study population  OR 
0.22 
(0.08 to 
0.59)  
398 
(2 RCTs)  
⨁◯◯◯ 
VERY LOW 1,2,3 
CRITICAL  
116 per 1000  
28 per 1000 
(10 to 72)  
All cause mortality (Death) 
assessed with death 
follow up range 1 weeks to 20 months  
Study population  OR 
1.47 
(0.82 to 
2.62)  
398 
(2 RCTs)  
⨁◯◯◯ 
VERY LOW 1,2,3 
CRITICAL  
116 pe 1000  
161 per 1000 
(97 to 255)  
Shunt Revision (Shunt. Rev) 
assessed with Redo surgery 
follow up range 1 weeks to 20 months  
Study population  OR 
0.66 
(0.26 to 
1.67)  
110 
(2 RCTs)  
⨁◯◯◯ 
VERY LOW 1,2,3 
CRITICAL 
167 per 1000  
117 per 1000 
(49 to 250)  
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and 
its 95% CI).  
 
CI Confidence interval; RR Risk ratio; OR Odds ratio;  
GRADE Working Group grades of evidence 
High quality We are very confident that the true effect lies close to that of the estimate of the effect 
Moderate quality We are moderately confident in the effect estimate The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is 
substantially different 
Low quality Our confidence in the effect estimate is limited The true effect may be substantially different from the estimate of the effect 
Very low quality We have very little confidence in the effect estimate The true effect is likely to be substantially different from the estimate of effect  
1. unclear allocation concealment, random sequence allocation, blinding, incomplete outcome data, selective reporting for all studies 
2. did not comply to IOS rule for imprecision 
3. Indirectness. AICs are too expensive for our study setting 
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4.0 Discussion 
The quality of evidence for systemic antimicrobial 
prophylaxis was moderate while that for AICs was very 
low, using imprecision, indirectness, risk of bias and 
inconsistency. The two meta-analyses demonstrated the 
effectiveness of systemic antibiotics as well as antibiotic 
impregnated shunts in preventing surgical site 
infections. These findings are consistent with other 
studies (Ratilal et al, 2009; Bratzler et al, 2013).  
Although there are many causes of mortality in surgical 
patients, adverse effects of antibiotics can play a role 
(Bratzler, 2013). In the second meta-analysis, the use of 
antibiotic impregnated shunt catheters was associated 
with a higher risk of mortality than standard shunts 
(Govender 2003, Zabramski 2003). There is paucity of 
data on the relationship between the use of intracranial 
ventricular shunts and all-cause mortality ( Ratilal et al, 
2006), although  AICs have been shown to be effective 
in preventing surgical site infections, which in turn, 
reduces infection related morbidity and mortality ( 
Parker et al, 2011).  
Although there is scanty literature on the development 
of non-surgical site infections in neurosurgical patients, 
several studies have documented ventilator associated 
pneumonia, catheter related urinary tract infections,  
ventriculitis, meningitis, blood stream infections, 
intravascular catheter related infections, lower 
respiratory tract infections and gastrointestinal 
infections  as the most common ones (Kourbeti et al, 
2012; Kupronis et al, 2004).  
Adverse effects of antibiotics occur commonly, but the 
life threatening ones are rare. Even though most studies 
did not evaluate this outcome, it is important to note the 
adverse effects as some serious and life threatening 
ones may occur.   
Only one study evaluated shunt revision (Govender 
2003) and demonstrated that use of AICs protected 
patients against shunt related infections.  Shunt revision 
was done for non-infective and not infective causes. 
There was no evidence of infection during the 
procedure. This is in agreement with similar studies 
(Cui et al, 2015).   
Overall, our systematic review is in agreement with 
Ratilal et al, (2008), as it shows the benefit of systemic 
antimicrobial prophylaxis in preventing neurosurgical 
site infections. In both systematic reviews, the efficacy 
of antimicrobial impregnated shunts could not be 
determined.  
Our study had several limitations. The studies obtained 
were generated from three databases only- The CDSR, 
CENTRAL and MEDLINE. Other databases like EMBASE 
could not be accessed. There was a paucity of studies 
from low and middle income countries and this affected 
the quality of evidence, with regard to directness of 
evidence. Some outcomes of interest like all- cause 
mortality and adverse effects of antibiotics were not 
evaluated by most studies. Our study excluded studies 
that compared the use of different antibiotics in 
preventing surgical site infections and those that were 
not in English.  
5.0 Conclusion 
Antimicrobial prophylaxis using systemic antibiotics or 
antibiotic impregnated shunt catheters is effective in 
preventing neurosurgical site infections. Antibiotic 
impregnated shunts are expensive to acquire but are 
associated with overall reduction in treatment and 
hospitalisation costs. 
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